Example: Heart Attack

Clinical Trials Sponsored by KuDOS Pharmaceuticals Limited

Total 5 results

NCT00633269

Completed

Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours

Conditions: Neoplasm Metastasis
NCT00516802

Completed

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Conditions: Melanoma Neoplasms
NCT00516438

Completed

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan

Conditions: Malignant Solid Tumors
NCT00494442

Completed

Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer

Conditions: Ovarian Neoplasm
NCT00494234

Active, not recruiting

Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer

Conditions: Breast Neoplasms